key: cord-0909772-hfukql9j authors: Hurst, Kelly T.; Ballard, Elizabeth D.; Anderson, Grace E.; Greenstein, Dede K.; Cavanaugh, Grace W.; Dwyer, Elspeth; Swartz, Kimberly; Zarate, Carlos A.; Chung, Joyce Y.; Park, Lawrence T. title: The Mental Health Impact of Contact with COVID-19 Patients on Healthcare Workers in the United States date: 2021-12-25 journal: Psychiatry Res DOI: 10.1016/j.psychres.2021.114359 sha: a8995e775d36ffc06795615dbba81bad16f71f67 doc_id: 909772 cord_uid: hfukql9j This study assessed the relationship between contact with COVID-19 patients and the mental health of healthcare workers (HCWs) in the United States (US). In a convenience sample of 957 HCWs who completed an anonymous online survey between April-May 2020, HCWs who provided direct care to confirmed or suspected COVID-19 patients reported increased depressive and posttraumatic symptoms compared to HCWs with no COVID-19 patient contact. Additionally, more frequent contact was associated with higher distress. More data drawn from diverse samples that better represent US HCWs are needed to fully assess the scope of this association. The COVID-19 pandemic has been associated with increased symptoms of anxiety, depression, and trauma-related conditions, and healthcare workers (HCWs) are particularly vulnerable (Marvaldi et al., 2021; Uphoff et al., 2021) . Internationally, front-line HCWs (i.e., those who have direct contact with patients) appear at elevated risk for negative mental health outcomes, although prevalence rates vary widely (Moitra et al., 2021; Uphoff et al., 2021) . Early in the pandemic in the US, HCWs reported significant distress (Schechter et al., 2020; Young et al., 2021) . However, relatively little is known about the specific impact of greater contact with COVID-19 patients. Some (Sagherian et al., 2020) , but not all (Hennein et al., 2021) , US data have suggested that front-line HCWs report higher distress than those with less or no patient interaction. This study sought to assess whether increased contact (i.e., providing direct care and/or having more frequent contact) with COVID-19 patients was associated with increased negative mental health symptoms among HCWs. Participants were recruited online using convenience sampling between April 24-May 25, 2020-a period of nearly universal "lockdown"/stay-at-home orders in the US. Study staff shared the study website through direct email, listservs, and social media. Although snowball sampling was not explicitly used, study authors' colleagues may have participated (anonymously) and encouraged HCWs in their professional networks to participate, who then shared the study with others. Any adult who could read/write English and self-identified as working in healthcare in any capacity was eligible. Participants (n=957) were predominantly white (90.1%) and female (84.2%). Although most (60.1%) HCWs were working outside the home, many reported teleworking sometimes (20.9%) or always (18.5%) at assessment. Demographic information is provided in Supplementary Table S1. Analyses included participants who completed at least one of the psychological measures (Table 1 and Supplementary Fig. S1 ). This study was exempt from full review by the NIH Institutional Review Board. Participation was anonymous, although respondents could provide their email for follow-up surveys. Only a subset of baseline data is presented here. Respondents were given links to mental health resources, including crisis phone numbers. The following instruments were used to measure mental health symptoms: 1) The 5-item Kessler Psychological Distress Scale , a brief measure of distress that includes symptoms of anxiety and depression (Kessler et al., 2002) ; 2) The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure for adults (DSM-XC), which assesses the frequency and severity of transdiagnostic psychiatric symptoms ranging from "none/not at all" (0) to "severe/nearly every day" (4) (American Psychiatric Association, 2013). Only depressive symptoms (depressed mood and anhedonia) are presented here; 3) The National Stressful Events Survey for Posttraumatic Stress Disorder-Short Scale (NSESSS), which assesses the severity of posttraumatic stress symptoms (e.g., flashbacks, feeling easily startled) during the past week (LeBeau et al., 2014) . Two survey items assessed workplace contact with COVID-19 patients. The first asked, "What is your level of contact with patients who have COVID-19 (or those suspected of having COVID-19)?" with response options: "I provide direct care or treatment to COVID-19 patients" (Direct Care); "I don't provide direct care or treatment, but I have direct contact or interaction with COVID-19 patients" (Direct Contact); "I don't provide care or interact with COVID-19 patients, but I support clinical services in another way" (No Contact); or "Other" (with space to provide additional details). "Other" responses (n=102) were then recategorized into one of the three primary groups (e.g., HCWs treating symptomatic patients who had not yet received positive tests were recategorized as Direct Care). The second item asked: "On average, how many days of the week are you in direct contact with COVID-19 patients (or those suspected of having COVID-19)?" (0-7). The association between contact with COVID-19 patients and outcome measures was assessed with quantile regression, which was used because of marked right skewness that was not sufficiently managed with log transformations. All models included sex and age as covariates and allowed for nonlinear age effects using restricted cubic splines. Model estimates and bootstrap confidence intervals are reported rather than p-values. All statistics were performed in R (www.r-project.org). The Direct Care group reported higher depressive and posttraumatic symptoms than the No Contact group. The Direct Contact group reported higher posttraumatic stress symptoms than the No Contact group. No additional psychological differences were detected between groups. More days/week of contact with COVID-19 patients corresponded to higher scores on all outcome measures. See Table 1 for details. Front-line HCWs and/or those with more frequent COVID-19 patient contact may be at elevated risk for psychological symptomatology. Findings may reflect the additional mental health burden borne by HCWs directly caring for COVID-19 patients. HCWs were surveyed during the first peak of COVID-19 across the US, using relatively accessible methods (i.e., online, anonymous). All HCWs were recruited, generating responses from nurses, mental health providers, physicians, physician assistants, occupational therapists, and support staff, among others. However, several limitations significantly restrict the conclusions that can be drawn, most notably the biased sample recruited via convenience sampling. Most participants were white and/or female, as with some other US studies (e.g., (Young et al., 2021) ). As a result, the present sample does not adequately reflect the diverse US healthcare workforce. This may be due to the fact that nurses and mental health providers were overrepresented in our sample (28.2% and 19.9% respectively). In the US, approximately 75% of full-time HCWs are female, and approximately two-thirds of health care technicians and practitioners (e.g., nurses, physicians) identify as non-Hispanic white (United States Census Bureau, 2021). Recruitment methods (e.g., word-of-mouth from researchers, including several psychiatrists), the online format, and the time required to participate (up to 30mins) likely biased the sample towards mental healthcare providers and/or other professions more likely to be teleworking early in the pandemic. Future studies should systematically recruit more racially/ethnically diverse samples that represent US HCWs, especially because US COVID-19 hospitalizations and deaths have disproportionately affected communities of color (Centers for Disease Control and Prevention, 2021). Considering the diversity and complexity of HCWs' experiences-and the potential for burnout and worsening mental health with prolonged exposure to COVID-19 patients-largescale, longitudinal assessment of HCWs' mental health is needed to inform comprehensive interventions that support clinician wellbeing. Funding for this work was provided by the Intramural Research Program at the National Institute of Mental Health, National Institutes of Health (IRP-NIMH-NIH; ZIAMH002927). The NIMH had no further role in study design; in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. Dr. Zarate is listed as a co-inventor on a patent for the use of ketamine in major depression and suicidal ideation; as a co-inventor on a patent for the use of (2R,6R)-hydroxynorketamine, (S)-dehydronorketamine, and other stereoisomeric dehydroxylated and hydroxylated metabolites of (R,S)-ketamine metabolites in the treatment of depression and neuropathic pain; and as a co-inventor on a patent application for the use of (2R,6R)hydroxynorketamine and (2S,6S)-hydroxynorketamine in the treatment of depression, anxiety, anhedonia, suicidal ideation, and post-traumatic stress disorders. He has assigned his patent rights to the US government but will share a percentage of any royalties that may be received by the government. Dr. Hurst is a contractor for Concentric Methods, Manassas, Virginia. All other authors have no conflict of interest to disclose, financial or otherwise. LTP: Conceptualized the study; designed the study; helped interpret the statistical analysis; revised the manuscript; provided research supervision. Online Assessment Measures: DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure Risk for COVID-19 Infection, Hospitalization, and Death by Race/Ethnicity Socio-ecological predictors of mental health outcomes among healthcare workers during the COVID-19 pandemic in the United States Short screening scales to monitor population prevalences and trends in non-specific psychological distress Dimensional assessment of posttraumatic stress disorder in DSM-5 Anxiety, depression, trauma-related, and sleep disorders among healthcare workers during the COVID-19 pandemic: A systematic review and metaanalysis Mental Health Consequences for Healthcare Workers During the COVID-19 Pandemic: A Scoping Review to Draw Lessons for LMICs Insomnia, fatigue and psychosocial well-being during COVID-19 pandemic: A cross-sectional survey of hospital nursing staff in the United States Psychological distress, coping behaviors, and preferences for support among New York healthcare workers during the COVID-19 pandemic 22 million employed in health care fight against COVID-19 Mental health among healthcare workers and other vulnerable groups during the COVID-19 pandemic and other coronavirus outbreaks: A rapid systematic review Health Care Workers' Mental Health and Quality of Life During COVID-19: Results From a Mid-Pandemic, National Survey The authors wish to thank all the healthcare workers who shared their experiences with us, giving their valuable time and energy while continuing to care for members of their communities during this global health crisis. The authors also thank the 7SE research unit and staff for their support. Ioline Henter (NIMH) provided invaluable editorial assistance.